Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase. / Bradić, Ivan; Liesinger, Laura; Kuentzel, Katharina B.; Vujić, Nemanja; Trauner, Michael; Birner-Gruenberger, Ruth; Kratky, Dagmar.

In: Journal of Lipid Research, Vol. 64, No. 9, 100427, 2023.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Bradić, I, Liesinger, L, Kuentzel, KB, Vujić, N, Trauner, M, Birner-Gruenberger, R & Kratky, D 2023, 'Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase', Journal of Lipid Research, vol. 64, no. 9, 100427. https://doi.org/10.1016/j.jlr.2023.100427

APA

Bradić, I., Liesinger, L., Kuentzel, K. B., Vujić, N., Trauner, M., Birner-Gruenberger, R., & Kratky, D. (2023). Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase. Journal of Lipid Research, 64(9), [100427]. https://doi.org/10.1016/j.jlr.2023.100427

Vancouver

Bradić I, Liesinger L, Kuentzel KB, Vujić N, Trauner M, Birner-Gruenberger R et al. Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase. Journal of Lipid Research. 2023;64(9). 100427. https://doi.org/10.1016/j.jlr.2023.100427

Author

Bradić, Ivan ; Liesinger, Laura ; Kuentzel, Katharina B. ; Vujić, Nemanja ; Trauner, Michael ; Birner-Gruenberger, Ruth ; Kratky, Dagmar. / Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase. In: Journal of Lipid Research. 2023 ; Vol. 64, No. 9.

Bibtex

@article{7a6537cf51394f3cb9340c5722e257fe,
title = "Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase",
abstract = "Lysosomal acid lipase (LAL) is the sole lysosomal enzyme responsible for the degradation of cholesteryl esters and triacylglycerols at acidic pH. Impaired LAL activity leads to LAL deficiency (LAL-D), a severe and fatal disease characterized by ectopic lysosomal lipid accumulation. Reduced LAL activity also contributes to the development and progression of non-alcoholic fatty liver disease (NAFLD). To advance our understanding of LALrelated liver pathologies, we performed comprehensive proteomic profiling of livers from mice with systemic genetic loss of LAL (Lal-/-) and from mice with hepatocyte-specific LAL-D (hepLal-/-). Lal-/- mice exhibited drastic proteome alterations, including dysregulation of multiple proteins related to metabolism, inflammation, liver fibrosis, and cancer. Global loss of LAL activity impaired both acidic and neutral lipase activities and resulted in hepatic lipid accumulation, indicating a complete metabolic shift in Lal-/- livers. Hepatic inflammation and immune cell infiltration were evident, with numerous upregulated inflammationrelated gene ontology biological process terms. In contrast, both young and mature hepLal-/- mice displayed only minor changes in the liver proteome, suggesting that loss of LAL solely in hepatocytes does not phenocopy metabolic alterations observed in mice globally lacking LAL. These findings provide valuable insights into the mechanisms underlying liver dysfunction in LAL-D and may help in understanding why decreased LAL activity contributes to NAFLD. Our study highlights the importance of LAL in maintaining liver homeostasis and demonstrates the drastic consequences of its global deficiency on the liver proteome and liver function.",
keywords = "cholesterol, cholesterol ester storage disease, lipase/lysosomal, lipid metabolism, lipids, liver, lysosomal storage disorder, non-alcoholic fatty liver disease, proteomics",
author = "Ivan Bradi{\'c} and Laura Liesinger and Kuentzel, {Katharina B.} and Nemanja Vuji{\'c} and Michael Trauner and Ruth Birner-Gruenberger and Dagmar Kratky",
note = "Publisher Copyright: {\textcopyright} 2023 THE AUTHORS.",
year = "2023",
doi = "10.1016/j.jlr.2023.100427",
language = "English",
volume = "64",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology, Inc.",
number = "9",

}

RIS

TY - JOUR

T1 - Metabolic changes and propensity for inflammation, fibrosis, and cancer in livers of mice lacking lysosomal acid lipase

AU - Bradić, Ivan

AU - Liesinger, Laura

AU - Kuentzel, Katharina B.

AU - Vujić, Nemanja

AU - Trauner, Michael

AU - Birner-Gruenberger, Ruth

AU - Kratky, Dagmar

N1 - Publisher Copyright: © 2023 THE AUTHORS.

PY - 2023

Y1 - 2023

N2 - Lysosomal acid lipase (LAL) is the sole lysosomal enzyme responsible for the degradation of cholesteryl esters and triacylglycerols at acidic pH. Impaired LAL activity leads to LAL deficiency (LAL-D), a severe and fatal disease characterized by ectopic lysosomal lipid accumulation. Reduced LAL activity also contributes to the development and progression of non-alcoholic fatty liver disease (NAFLD). To advance our understanding of LALrelated liver pathologies, we performed comprehensive proteomic profiling of livers from mice with systemic genetic loss of LAL (Lal-/-) and from mice with hepatocyte-specific LAL-D (hepLal-/-). Lal-/- mice exhibited drastic proteome alterations, including dysregulation of multiple proteins related to metabolism, inflammation, liver fibrosis, and cancer. Global loss of LAL activity impaired both acidic and neutral lipase activities and resulted in hepatic lipid accumulation, indicating a complete metabolic shift in Lal-/- livers. Hepatic inflammation and immune cell infiltration were evident, with numerous upregulated inflammationrelated gene ontology biological process terms. In contrast, both young and mature hepLal-/- mice displayed only minor changes in the liver proteome, suggesting that loss of LAL solely in hepatocytes does not phenocopy metabolic alterations observed in mice globally lacking LAL. These findings provide valuable insights into the mechanisms underlying liver dysfunction in LAL-D and may help in understanding why decreased LAL activity contributes to NAFLD. Our study highlights the importance of LAL in maintaining liver homeostasis and demonstrates the drastic consequences of its global deficiency on the liver proteome and liver function.

AB - Lysosomal acid lipase (LAL) is the sole lysosomal enzyme responsible for the degradation of cholesteryl esters and triacylglycerols at acidic pH. Impaired LAL activity leads to LAL deficiency (LAL-D), a severe and fatal disease characterized by ectopic lysosomal lipid accumulation. Reduced LAL activity also contributes to the development and progression of non-alcoholic fatty liver disease (NAFLD). To advance our understanding of LALrelated liver pathologies, we performed comprehensive proteomic profiling of livers from mice with systemic genetic loss of LAL (Lal-/-) and from mice with hepatocyte-specific LAL-D (hepLal-/-). Lal-/- mice exhibited drastic proteome alterations, including dysregulation of multiple proteins related to metabolism, inflammation, liver fibrosis, and cancer. Global loss of LAL activity impaired both acidic and neutral lipase activities and resulted in hepatic lipid accumulation, indicating a complete metabolic shift in Lal-/- livers. Hepatic inflammation and immune cell infiltration were evident, with numerous upregulated inflammationrelated gene ontology biological process terms. In contrast, both young and mature hepLal-/- mice displayed only minor changes in the liver proteome, suggesting that loss of LAL solely in hepatocytes does not phenocopy metabolic alterations observed in mice globally lacking LAL. These findings provide valuable insights into the mechanisms underlying liver dysfunction in LAL-D and may help in understanding why decreased LAL activity contributes to NAFLD. Our study highlights the importance of LAL in maintaining liver homeostasis and demonstrates the drastic consequences of its global deficiency on the liver proteome and liver function.

KW - cholesterol

KW - cholesterol ester storage disease

KW - lipase/lysosomal

KW - lipid metabolism

KW - lipids

KW - liver

KW - lysosomal storage disorder

KW - non-alcoholic fatty liver disease

KW - proteomics

U2 - 10.1016/j.jlr.2023.100427

DO - 10.1016/j.jlr.2023.100427

M3 - Journal article

C2 - 37595802

AN - SCOPUS:85172707051

VL - 64

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 9

M1 - 100427

ER -

ID: 369254843